$VGNT News

Versigent (VGNT) Price Target Increased by 15.06% to 47.53

UBS Maintains Buy on Versigent, Raises Price Target to $49

TD Cowen Maintains Buy on Versigent, Raises Price Target to $49

Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $42

Versigent PLC (VGNT) Q1 2026 Earnings Call Transcript

Versigent PLC 2026 Q1 - Results - Earnings Call Presentation

Versigent Sees FY2026 Sales $9.100B-$9.400B

Versigent Q1 Sales $2.212B Up From $2.024B YoY

Versigent (VGNT) Price Target Increased by 23.98% to 41.31

Deutsche Bank Initiates Coverage of Versigent (VGNT) with Hold Recommendation

Deutsche Bank Initiates Coverage On Versigent with Hold Rating, Announces Price Target of $35

Versigent (VGNT) Price Target Increased by 16.67% to 33.32

Versigent: Valuation Should Re-Rate Upwards If Management Hits Guidance

UBS Initiates Coverage of Versigent (VGNT) with Buy Recommendation

Versigent shares are trading higher after UBS initiated its coverage on the stock with a Buy rating and announced a price target of $43.

Versigent shares are trading higher after UBS initiated its coverage on the stock with a Buy rating and announced a price target of $43.

UBS Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $43

Discovering US Undiscovered Gems with Potential In April 2026

Is Versigent (VGNT) Offering A Valuation Opportunity After Recent Share Price Weakness

Wells Fargo Initiates Coverage On Versigent with Overweight Rating, Announces Price Target of $35